Skip to main content
Premium Trial:

Request an Annual Quote

CIL, MRM Proteomics Ink Supply Deal for Targeted Proteomics Assays

NEW YORK (GenomeWeb) – Cambridge Isotope Laboratories and MRM Proteomics said yesterday that they have signed an exclusive global supply agreement for mass spec-based targeted proteomics assays.

Under the agreement, CIL will have exclusive selling rights to MRM Proteomics' PeptiQuant kits used for quantitative proteomics and will provide distribution for the products worldwide.

The most widely used mass spec approach for targeted protein quantitation, MRM-MS assays typically incorporate stable isotope labeled (SIL) peptides to improve their accuracy and reproducibility.

MRM Proteomics currently offers PeptiQuant kits for the measurement of 76 proteins associated with various diseases as well as for mass spec QC work. Under the agreement, the two companies plan to develop additional kits for specific disease areas and for quantitative metabolomics research.

"CIL is the world's leading producer and supplier of stable isotope enriched small molecules to the mass spectrometry community," MRM Proteomics CEO Gary Kruppa said in a statement. "CIL knows our market and customers already and has excellent sales and distribution channels worldwide."

Financial and other terms of the agreement were not disclosed.

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.